Investing.com - Bristol-Myers Squibb (NYSE:BMY) reported on Wednesday third quarter earnings that beat analysts' forecasts and revenue that was inline with expectations.
Bristol-Myers Squibb announced earnings per share of $2 on revenue of $11.62B. Analysts polled by Investing.com anticipated EPS of $1.93 on revenue of $11.62B.
Bristol-Myers Squibb shares are up 37.46% from the beginning of the year and are trading at $58.24 , down-from-52-week-high.They are outperforming the S&P 500 which is up 21.8% from the start of the year.
Bristol-Myers Squibb follows other major Healthcare sector earnings this month
Bristol-Myers Squibb's report follows an earnings beat by J&J on Tuesday, October 19, 2021, who reported EPS of $2.6 on revenue of $23.34B, compared to forecasts EPS of $2.35 on revenue of $23.64B.
Thermo Fisher Scientific had beat expectations on Wednesday with third quarter EPS of $5.76 on revenue of $9.33B, compared to forecast for EPS of $4.68 on revenue of $8.33B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar